Evidence map›Paper›PMID 31471767›Full record

ArticleObesity surgery2020

Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 Diabetes.

Laurel L Tangalakis, Lawrence Tabone, Anna Spagnoli, Mike Muehlbauer, Philip Omotosho, Alfonso Torquati

Open access · greenAbstract readControlled Clinical Trial
In one paragraph

Article in Obesity surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laurel L TangalakisDepartment of Surgery, Rush University Medical Center, 1750 W Harrison St, 791 Jelke, Chicago, IL, 60612, USA. laurel_l_tangalakis@rush.edu.ORCID 0000-0002-3716-5824
Lawrence TaboneDepartment of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Anna SpagnoliDepartment of Surgery, Rush University Medical Center, 1750 W Harrison St, 791 Jelke, Chicago, IL, 60612, USA.
Mike MuehlbauerSarah W. Steadman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina, USA.
Philip OmotoshoDepartment of Surgery, Rush University Medical Center, 1750 W Harrison St, 791 Jelke, Chicago, IL, 60612, USA.
Alfonso TorquatiDepartment of Surgery, Rush University Medical Center, 1750 W Harrison St, 791 Jelke, Chicago, IL, 60612, USA.
Rush University Medical Center · USDuke Medical Center · USDuke University · US

Funding

Impact of gastric bypass surgery on risk of CVD in type 2 diabetes mellitusK23DK075907 · NIDDK · VANDERBILT UNIVERSITY · PI TORQUATI, ALFONSO · 2006 to 2009
$594k
NIDDK NIH HHS K23 DK075907
6 · The paper itself

Abstract

introductionRoux-en-Y gastric bypass (RYGB) is a well-established treatment for morbid obesity and type 2 diabetes. The effects of RYGB on bone metabolism and bone health are largely unknown.

objectiveDetermine the changes in osteoclast function and bone density 1 year after RYGB as compared with a control group undergoing a diabetes support and education program (DSE).

designA prospective cohort study with patients matched for weight and age assigned to RYGB or DSE.

settingLarge academic institution. PATIENTS OR OTHER

participantsPatients with type 2 diabetes mellitus and morbid obesity (body mass index greater than 35 kg/m

interventionSubjects either received laparoscopic RYBG or DSE, which consisted of nutritional, exercise, and dietary counseling performed by a certified diabetic educator and a nutritionist three times over a year.

main outcome measureOsteoclast activity, bone mineral density.

resultsOne year after, intervention subjects undergoing RYGB have a 280% increase in osteoclast activity as compared with a 7.6% increase in the DSE control group (P < 0.001). Furthermore, there was a statistically significant increase in sclerostin levels in subjects undergoing RYGB compared with an increase in the control group. The total bone mineral density was statistically unchanged within 1 year of intervention in both groups. A statistically significant decrease in bone mineral density in the left ribs (decrease of 6.8%, P < 0.05) and lumbar spine (decrease of 4.0%, P < 0.05) was seen 1 year after RYGB.

conclusionsThere is a significant increase in osteoclast activity observed 1 year after RYGB; the long-term clinical implications of this increased bone metabolism are unknown.

Indexed as

Gastric BypassAdultBody Mass IndexBone DensityDiabetes Mellitus, Type 2FemaleHumansLaparoscopyMaleMiddle AgedMorbidityObesity, MorbidOsteoclastsProspective StudiesWeight LossBariatric surgeryBone lossBone mineral densityOsteoclastRoux-en-Y gastric bypass

Identifiers

PMID31471767
PMCPMC7515205
OpenAlexW2970571938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.